Cargando…
Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and...
Autores principales: | Gamougam, Kadidja, Daugla, Doumagoum M., Toralta, Jacques, Ngadoua, Cyriaque, Fermon, Florence, Page, Anne-Laure, Djingarey, Mamoudou H., Caugant, Dominique A., Manigart, Olivier, Trotter, Caroline L., Stuart, James M., Greenwood, Brian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285275/ https://www.ncbi.nlm.nih.gov/pubmed/25536336 http://dx.doi.org/10.3201/eid2101.140256 |
Ejemplares similares
-
Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013) -
Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad
por: Diallo, Kanny, et al.
Publicado: (2017) -
Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015
por: Carville, Kylie S., et al.
Publicado: (2016) -
Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012
por: Cibrelus, Laurence, et al.
Publicado: (2015) -
Serogroup W135 Meningococcal Disease, The Gambia, 2012
por: Hossain, M. Jahangir, et al.
Publicado: (2013)